Physician

David Wade Redick, MD

According to 2025 Medicare claims, David Redick, MD (NPI: 1770078859) practices ophthalmology in the Bozeman, MT market, with the plurality of this provider's patient population coming from Gallatin, MT. This provider's primary affiliated billing organization is MARC F COMARATTA MD PC (NPI: 1578282620) and primary practice location at 59718-6851. Redick is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771), participating under the MSSP model.

Redick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 443 traditional Medicare patients, billed 2,914 HCPCS/CPT codes, and received $299,306 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 316 prescription claims across 135 beneficiaries totaling $20,002 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $1,815. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,481 to $20,002. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$150K$299K2022 Medicare payment: $5,701 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $13,592 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $299,306 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222652$5,701
2023169214$13,592
20244432,914$299,306

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$101K2018 Drug cost: $3,481 (USD; Tot_Drug_Cst)2019 Drug cost: $8,167 (USD; Tot_Drug_Cst)2020 Drug cost: $13,622 (USD; Tot_Drug_Cst)2021 Drug cost: $101,447 (USD; Tot_Drug_Cst)2022 Drug cost: $4,811 (USD; Tot_Drug_Cst)2023 Drug cost: $29,525 (USD; Tot_Drug_Cst)2024 Drug cost: $20,002 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182652$3,481
201955135$8,167
20204687$13,622
20212237$101,447
20224474$4,811
2023173383$29,525
2024135316$20,002

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system187192$94
67028Injection of drug into eye145269$93
92012Established patient problem focused exam of visual system90108$71
J9035Injection, bevacizumab, 10 mg87138$56
92134Imaging of retina399606$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1203,861$5,276
Ketorolac TromethamineKetorolac Tromethamine421,518$1,477
OfloxacinOfloxacin15320$169
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim21742$158
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat14851$137

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$1,815ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Wade Redick, MD?

Tedicare shows public-source Medicare data for David Wade Redick, MD (NPI 1770078859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Wade Redick, MD have ACO affiliation data?

David Wade Redick, MD is shown with ACO affiliation data for Emory Healthcare Network Advantage (MSSP, ACO ID A4771).

What billing organization is linked to David Wade Redick, MD?

David Wade Redick, MD is linked to MARC F COMARATTA MD PC (billing NPI 1578282620) in the available physician profile data.

Does David Wade Redick, MD have Open Payments data?

David Wade Redick, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.